- Price
- $29.17
- Day
- -2.96%
- Mkt Cap
- $1.80B
- 52W Range
- $2.45 – $38.33
- Volume
- 559.5K
- Beta
- 1.47
Find a company by name or ticker and open its page
Breaking news, press releases, and analyst updates.
Most recent articles and analysis covering this company.
BOSTON, Sept. 03, 2026 (GLOBE NEWSWIRE) -- Damora Therapeutics, Inc. (NASDAQ: DMRA) (“Damora”), a biotechnology company working to fundamentally redefine care for patients with blood disorders, today announced that it granted equity awards to three newly-hired, non-executive employees on September 1, 2026.
Read full article